...
首页> 外文期刊>American Journal of Physiology >Restoring multidrug resistance-associated protein 3 attenuates cell proliferation in the polycystic kidney
【24h】

Restoring multidrug resistance-associated protein 3 attenuates cell proliferation in the polycystic kidney

机译:恢复多药抗性相关的蛋白3衰减多囊肾中的细胞增殖

获取原文
获取原文并翻译 | 示例

摘要

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by abnormal proliferation of renal tubular epithelial cells, resulting in the loss of renal function. Despite identification of the genes responsible for ADPKD, few effective drugs are currently available for the disease. Thus finding additional effective drug targets is necessary. The functions of multidrug- resistance-associated protein 3 (MRP3) have been reported only in the field of drug resistance, and the renal functions of MRP3 are mostly unknown. In this study, we found that MRP3 was significantly downregulated in kidneys of human patients with ADPKD and polycystic kidney disease (PKD) mouse models. Our results suggest that downregulated MRP3 stimulated renal epithelial cell proliferation through the B-Raf/MEK/ERK signaling pathway. In contrast, we found that restoring MRP3 reduced cell proliferation and cystogenesis in vitro. These results suggest that the renal function of MRP3 is related to renal cell proliferation and cyst formation and that restoring MRP3 may be an effective therapeutic approach for PKD.
机译:常染色体占优势性多囊肾疾病(ADPKD)的特征在于肾小管上皮细胞异常增殖,导致肾功能丧失。尽管鉴定了对ADPKD负责的基因,但目前可用于该疾病的有效药物。因此,需要额外的有效药物目标。据报道,多种抗性相关蛋白3(MRP3)的功能仅在耐药领域报告,MRP3的肾功能大多是未知的。在这项研究中,我们发现MRP3在人类患者的肾脏和多囊肾疾病(PKD)小鼠模型中显着下调。我们的研究结果表明,下调的MRP3通过B-RAF / MEK / ERK信号通路刺激肾上皮细胞增殖。相比之下,我们发现恢复MRP3在体外减少细胞增殖和囊肠活。这些结果表明MRP3的肾功能与肾细胞增殖和囊肿形成有关,并且恢复MRP3可能是PKD的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号